NASDAQ · Biotechnology

NRX Pharmaceuticals, Inc. (NRXP) Stock

$2.87 -0.87% NASDAQ: NRXP Healthcare

Valuation

MetricValue
Price$2.87
Market Cap$124.04M
P/E Ratio-3.79
P/B Ratio-623.92
P/S Ratio35.94
EPS (TTM)$-1.34
52-Week High$5.06
52-Week Low$1.62
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE168.68%
ROA-68.74%
ROCE100.00%
Gross Margin-1600.00%
Operating Margin-1600.00%
Net Margin-691.81%
Debt/Equity-7.33
Current Ratio0.31

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$1.0M
Operating Profit$-95.0M$-44.0M$-28.0M$-20.0M$-16.0M
Net Profit$-93.0M$-40.0M$-30.0M$-25.0M$-29.0M
EPS$-7.44$-0.60$-3.98$-2.39$-1.34
Op Margin————-1324.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$33.0M$26.0M$7.0M$4.0M$13.0M
Total Liabilities$12.0M$18.0M$19.0M$27.0M$29.0M
Cash$28.0M$20.0M$5.0M$1.0M$8.0M
Borrowings$1.0M$11.0M$9.0M$7.0M$1.0M

Latest News

Is NRx Pharmaceuticals, Inc. (NRXP) Stock Positioned for Growth Through Depression and PTSD Treatment Innovation? Insider Monkey · Jul 15, 2026 NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute GlobeNewswire · Jun 25, 2026 NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System GlobeNewswire · Jun 25, 2026 Sector Update: Healthcare Stocks Advance Late Afternoon MT Newswires · Jun 24, 2026 Sector Update: Healthcare MT Newswires · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-38.0M$-40.0M$-22.0M$-11.0M$-14.0M
Investing Cash Flow$0$0$0$0$-3.0M
Financing Cash Flow$10.0M$0$0$3.0M$0
Net Cash Flow$26.0M$-8.0M$-15.0M$-3.0M$6.0M
Free Cash Flow$-38.0M$-40.0M$-22.0M$-11.0M$-14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA-4.40
FCF Yield-16.95%
Quick Ratio0.86
Interest Coverage-17.45
Return 1Y42.12%
Return 3Y19.46%
Return 5Y-94.81%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc. is led by CEO Jonathan C. Javitt, employs 2 people, headquartered in US, publicly traded since 2017.

NRX Pharmaceuticals, Inc. (NRXP) stock trades at $2.87 with a market capitalization of $124.04M. The stock is valued at a price-to-earnings (P/E) ratio of -3.79, price-to-book of -623.92, price-to-sales of 35.94. Over the past 52 weeks the stock has ranged between $1.62 and $5.06, and currently trades 43.3% below its 52-week high.

On profitability, NRX Pharmaceuticals, Inc. generates a return on equity (ROE) of 168.68% — well above the market average, a sign of a high-quality business, return on capital employed of 100.00%, an operating margin of -1600.00%, a net profit margin of -691.81%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides